Baker Bros. Advisors as of Dec. 31, 2020
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 126 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seagen | 31.2 | $8.3B | 47M | 175.14 | |
BeiGene Sponsored Adr (BGNE) | 11.4 | $3.0B | 12M | 258.39 | |
Incyte Corporation (INCY) | 10.5 | $2.8B | 32M | 86.98 | |
ACADIA Pharmaceuticals (ACAD) | 8.4 | $2.2B | 42M | 53.46 | |
Kodiak Sciences (KOD) | 7.7 | $2.0B | 14M | 146.91 | |
Alexion Pharmaceuticals | 5.2 | $1.4B | 8.8M | 156.24 | |
Prelude Therapeutics (PRLD) | 2.7 | $724M | 10M | 71.55 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $666M | 7.6M | 87.69 | |
Invitae (NVTAQ) | 2.5 | $654M | 16M | 41.81 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 2.2 | $590M | 3.5M | 166.78 | |
Abcellera Biologics (ABCL) | 1.6 | $421M | 11M | 40.24 | |
Mirati Therapeutics | 1.2 | $310M | 1.4M | 219.64 | |
argenx SE Sponsored Adr (ARGX) | 1.1 | $300M | 1.0M | 294.09 | |
Igm Biosciences (IGMS) | 1.0 | $278M | 3.1M | 88.29 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $167M | 1.5M | 111.17 | |
Amarin Corporation Sponsored Adr (AMRN) | 0.5 | $137M | 28M | 4.89 | |
Heron Therapeutics (HRTX) | 0.5 | $127M | 6.0M | 21.16 | |
Kymera Therapeutics (KYMR) | 0.5 | $122M | 2.0M | 62.00 | |
Allakos (ALLK) | 0.4 | $100M | 714k | 140.00 | |
Cerus Corporation (CERS) | 0.4 | $95M | 14M | 6.92 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $95M | 13M | 7.45 | |
Pacific Biosciences of California (PACB) | 0.3 | $83M | 3.2M | 25.94 | |
Zymeworks | 0.3 | $81M | 1.7M | 47.26 | |
Insmed Incorporated Com Par $.01 (INSM) | 0.3 | $72M | 2.2M | 33.29 | |
Forma Therapeutics Holdings SHS | 0.3 | $71M | 2.0M | 34.90 | |
Rhythm Pharmaceuticals (RYTM) | 0.3 | $69M | 2.3M | 29.73 | |
Neurocrine Biosciences (NBIX) | 0.2 | $65M | 677k | 95.85 | |
Axsome Therapeutics (AXSM) | 0.2 | $64M | 779k | 81.47 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $62M | 444k | 138.43 | |
Nurix Therapeutics (NRIX) | 0.2 | $59M | 1.8M | 32.88 | |
Atreca Cl A Com (BCEL) | 0.2 | $57M | 3.5M | 16.15 | |
Neoleukin Therapeutics | 0.2 | $54M | 3.8M | 14.10 | |
Adaptimmune Therapeutics Sponsored Adr (ADAP) | 0.2 | $53M | 9.8M | 5.39 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $51M | 897k | 57.20 | |
Kiniksa Pharmaceuticals Com Cl A | 0.2 | $50M | 2.8M | 17.67 | |
ADC Therapeutics SA SHS (ADCT) | 0.2 | $45M | 1.4M | 32.01 | |
Aligos Therapeutics (ALGS) | 0.2 | $45M | 1.6M | 27.65 | |
Horizon Therapeutics Public SHS | 0.2 | $44M | 599k | 73.15 | |
Krystal Biotech (KRYS) | 0.2 | $42M | 699k | 60.00 | |
Chemocentryx | 0.2 | $41M | 657k | 61.92 | |
Global Blood Therapeutics In | 0.2 | $40M | 920k | 43.31 | |
DBV Technologies Sponsored Adr | 0.1 | $38M | 15M | 2.62 | |
Opthea Sponsored Ads (OPT) | 0.1 | $37M | 3.3M | 11.21 | |
Merus N V (MRUS) | 0.1 | $36M | 2.0M | 17.53 | |
Alkermes SHS (ALKS) | 0.1 | $31M | 1.5M | 19.95 | |
Frequency Therapeutics | 0.1 | $30M | 857k | 35.26 | |
Protagonist Therapeutics (PTGX) | 0.1 | $29M | 1.4M | 20.16 | |
Bioatla (BCAB) | 0.1 | $28M | 825k | 34.01 | |
Reata Pharmaceuticals Cl A | 0.1 | $28M | 224k | 123.62 | |
Athira Pharma (ATHA) | 0.1 | $28M | 806k | 34.25 | |
Aeglea Biotherapeutics | 0.1 | $27M | 3.4M | 7.87 | |
Fulgent Genetics (FLGT) | 0.1 | $26M | 496k | 52.10 | |
Adaptive Biotechnologies Cor (ADPT) | 0.1 | $23M | 380k | 59.13 | |
Verastem | 0.1 | $22M | 10M | 2.13 | |
Mereo BioPharma Group Ads (MREO) | 0.1 | $22M | 6.0M | 3.58 | |
Altimmune (ALT) | 0.1 | $21M | 1.9M | 11.28 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $20M | 1.4M | 13.83 | |
Immatics SHS (IMTX) | 0.1 | $20M | 1.8M | 10.79 | |
Novavax (NVAX) | 0.1 | $19M | 170k | 111.51 | |
Idera Pharmaceuticals Com Par | 0.1 | $17M | 4.6M | 3.67 | |
Cymabay Therapeutics | 0.1 | $17M | 2.9M | 5.74 | |
Invitae Corporation Note 2.0% 9/1/2024 (Principal) | 0.1 | $16M | 10M | 1.60 | |
Xencor (XNCR) | 0.1 | $16M | 369k | 43.63 | |
BioMarin Pharmaceutical Note 0.599% 8/1/2024 (Principal) | 0.1 | $16M | 15M | 1.07 | |
Albireo Pharma | 0.1 | $16M | 413k | 37.51 | |
Sangamo Biosciences (SGMO) | 0.1 | $13M | 857k | 15.61 | |
GW Pharmaceuticals Ads | 0.0 | $13M | 113k | 115.41 | |
Gamida Cell SHS | 0.0 | $13M | 1.5M | 8.39 | |
Chinook Therapeutics | 0.0 | $12M | 749k | 15.86 | |
Five Prime Therapeutics | 0.0 | $11M | 668k | 17.01 | |
Mirum Pharmaceuticals (MIRM) | 0.0 | $11M | 647k | 17.46 | |
Silverback Therapeutics (SPRY) | 0.0 | $11M | 238k | 46.34 | |
Xenon Pharmaceuticals (XENE) | 0.0 | $11M | 687k | 15.38 | |
Bluebird Bio (BLUE) | 0.0 | $9.8M | 227k | 43.27 | |
Iveric Bio | 0.0 | $9.7M | 1.4M | 6.91 | |
Assembly Biosciences | 0.0 | $9.3M | 1.5M | 6.05 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $9.2M | 427k | 21.50 | |
Crinetics Pharmaceuticals In (CRNX) | 0.0 | $8.7M | 617k | 14.11 | |
Vaxart (VXRT) | 0.0 | $8.0M | 1.4M | 5.71 | |
Cabaletta Bio (CABA) | 0.0 | $7.9M | 636k | 12.48 | |
Hookipa Pharma Inc equity | 0.0 | $7.8M | 701k | 11.09 | |
Syros Pharmaceuticals | 0.0 | $7.5M | 690k | 10.85 | |
Denali Therapeutics (DNLI) | 0.0 | $7.4M | 89k | 83.76 | |
Karuna Therapeutics Ord | 0.0 | $7.1M | 70k | 101.59 | |
Autolus Therapeutics Sponsored Ads (AUTL) | 0.0 | $7.0M | 782k | 8.94 | |
Harmony Biosciences Hldgs In (HRMY) | 0.0 | $6.5M | 180k | 36.15 | |
Genetron Holdings Ads | 0.0 | $6.4M | 455k | 14.00 | |
Intellia Therapeutics (NTLA) | 0.0 | $6.1M | 111k | 54.40 | |
Passage Bio (PASG) | 0.0 | $6.0M | 235k | 25.57 | |
Replimune Group (REPL) | 0.0 | $5.9M | 154k | 38.15 | |
Iteos Therapeutics (ITOS) | 0.0 | $5.1M | 150k | 33.82 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $4.8M | 200k | 24.21 | |
Burning Rock Biotech Sponsored Ads | 0.0 | $4.8M | 209k | 23.10 | |
Gossamer Bio (GOSS) | 0.0 | $4.6M | 481k | 9.67 | |
Macrogenics (MGNX) | 0.0 | $4.6M | 201k | 22.86 | |
Tricida | 0.0 | $4.4M | 629k | 7.05 | |
Inflarx Nv (IFRX) | 0.0 | $4.3M | 856k | 5.03 | |
Alector (ALEC) | 0.0 | $3.6M | 239k | 15.13 | |
Logicbio Therapeutics | 0.0 | $3.4M | 452k | 7.63 | |
Tcr2 Therapeutics Inc cs | 0.0 | $3.4M | 111k | 30.93 | |
Constellation Pharmceticls I | 0.0 | $3.3M | 115k | 28.80 | |
Legend Biotech Corporation Sponsored Ads (LEGN) | 0.0 | $3.3M | 116k | 28.16 | |
Ngm Biopharmaceuticals | 0.0 | $3.2M | 107k | 30.30 | |
Chiasma | 0.0 | $3.2M | 742k | 4.35 | |
Akero Therapeutics (AKRO) | 0.0 | $3.1M | 118k | 25.80 | |
Acceleron Pharma | 0.0 | $2.9M | 22k | 127.95 | |
Dicerna Pharmaceuticals | 0.0 | $2.3M | 102k | 22.03 | |
Ovid Therapeutics (OVID) | 0.0 | $2.2M | 956k | 2.31 | |
Inozyme Pharma (INZY) | 0.0 | $2.2M | 107k | 20.64 | |
Viking Therapeutics (VKTX) | 0.0 | $2.0M | 364k | 5.63 | |
Arcus Biosciences Incorporated (RCUS) | 0.0 | $1.9M | 73k | 25.97 | |
Orchard Therapeutics Ads | 0.0 | $1.4M | 333k | 4.32 | |
Leap Therapeutics | 0.0 | $1.3M | 560k | 2.25 | |
Molecular Templates | 0.0 | $1.3M | 134k | 9.39 | |
Oyster Point Pharma | 0.0 | $1.2M | 61k | 18.82 | |
Galapagos NV Sponsored Adr (GLPG) | 0.0 | $1.1M | 11k | 99.02 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $1.1M | 522k | 2.12 | |
Evofem Biosciences | 0.0 | $991k | 411k | 2.41 | |
Affimed Therapeutics B V | 0.0 | $958k | 165k | 5.82 | |
Bellicum Pharmaceuticals | 0.0 | $879k | 249k | 3.53 | |
Kezar Life Sciences (KZR) | 0.0 | $729k | 140k | 5.22 | |
Adamas Pharmaceuticals | 0.0 | $641k | 148k | 4.33 | |
Galmed Pharmaceuticals SHS | 0.0 | $575k | 185k | 3.11 | |
uniQure SHS (QURE) | 0.0 | $244k | 6.7k | 36.20 | |
Sunesis Pharmaceuticals | 0.0 | $106k | 53k | 2.00 | |
Genfit SA Ads (GNFT) | 0.0 | $71k | 15k | 4.82 |